Abstract
A separation of honokiol 1 from the closely structurally related magnolol 2 was developed. Honokiol demonstrated weak activity against HIV-1 in human lymphocytes.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Animals
-
Antineoplastic Agents, Phytogenic / isolation & purification*
-
Antineoplastic Agents, Phytogenic / pharmacology
-
Antiviral Agents / isolation & purification*
-
Antiviral Agents / pharmacology
-
Biphenyl Compounds / isolation & purification*
-
Biphenyl Compounds / pharmacology
-
Cell Line, Tumor
-
Chlorocebus aethiops
-
Drug Screening Assays, Antitumor
-
Humans
-
In Vitro Techniques
-
Leukocytes, Mononuclear / drug effects
-
Leukocytes, Mononuclear / virology
-
Lignans / isolation & purification*
-
Lignans / pharmacology
-
Vero Cells
Substances
-
Antineoplastic Agents, Phytogenic
-
Antiviral Agents
-
Biphenyl Compounds
-
Lignans
-
magnolol
-
honokiol